<bill session="109" type="s" number="2793" updated="2013-07-19T20:37:52-04:00">
  <state datetime="2006-05-11">REFERRED</state>
  <status>
    <introduced datetime="2006-05-11"/>
  </status>
  <introduced datetime="2006-05-11"/>
  <titles>
    <title as="introduced" type="short">Pharmaceutical Technology and Education Enhancement Act</title>
    <title as="introduced" type="official">A bill to enhance research and education in the areas of pharmaceutical and biotechnology science and engineering, including therapy development and manufacturing, analytical technologies, modeling, and informatics.</title>
  </titles>
  <sponsor id="300070"/>
  <cosponsors>
    <cosponsor id="300083" joined="2006-07-18"/>
  </cosponsors>
  <actions>
    <action datetime="2006-05-11">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S4476-4477"/>
    </action>
    <action state="REFERRED" datetime="2006-05-11">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drug industry"/>
    <term name="Economics and public finance"/>
    <term name="Education"/>
    <term name="Federal advisory bodies"/>
    <term name="Federal aid to education"/>
    <term name="Federal aid to research"/>
    <term name="Government operations and politics"/>
    <term name="Higher education"/>
    <term name="Medical technology"/>
    <term name="Pharmaceutical research"/>
    <term name="Quality of products"/>
    <term name="Science, technology, communications"/>
  </subjects>
  <amendments/>
  <summary>5/11/2006--Introduced.
Pharmaceutical Technology and Education Enhancement Act - Requires the Commissioner of Food and Drugs to expand and intensify certain research and education programs regarding pharmaceutical science and engineering through the National Institute for Pharmaceutical Technology and Education (NIPTE) and its member institutions. Requires such programs to focus on medical therapy development and manufacturing, analytical technologies, modeling, and informatics. Requires the Commissioner to establish a Coordinating Committee to: (1) assist with and coordinate research and develop strategies for the rapid design, enhanced manufacturing process, and improved quality of new medical technology; and (2) develop a plan for supporting, through NIPTE and federal agency participants, research and education relating to medical technology development and manufacturing.</summary>
</bill>
